Position Statements
ESVCE Position Statement on CBD Use in Veterinary Behavioural Medicine
February 12, 2026
The ESVCE is pleased to announce the publication of a new position statement on the use of cannabidiol (CBD) in veterinary behavioural medicine, prepared by the CBD Working Group.
Background
The increasing popularity of CBD-containing products for companion animals, combined with evolving legal frameworks across European countries, prompted the ESVCE to convene a working group to review the scientific evidence systematically.
Key Areas Reviewed
- Scientific review of cannabidiol pharmacology and effects in dogs
- Review of CBD-containing products and differences in composition
- Assessment of effectiveness for canine behavioural issues
- Analysis of global legal regulations concerning CBD and THC
Working Group
The position statement was prepared by Dr. Stéphane Bleuer, Dr. Sylvia Masson, and Dr. Matthieu Broussois.
The full position statement is available on our Position Statements page. We encourage members to share this with colleagues and refer to it in clinical practice.